How to Get Provigil (Modafinil) in Wyoming

Wyoming Telehealth Rules for Modafinil Prescriptions

Wyoming permits licensed prescribers to prescribe Schedule IV controlled substances, including modafinil, via telehealth. The Wyoming Board of Medicine and the Wyoming State Board of Pharmacy both recognize audio-video telehealth encounters as sufficient for establishing a prescriber-patient relationship for Schedule IV drugs. This means you do not need an in-person office visit to receive a modafinil prescription in the state.

The DEA's updated telemedicine policies effective since 2025 permit Schedule III through V prescriptions via telehealth when conducted by a DEA-registered practitioner using a real-time audio-video platform. Wyoming adopted these federal allowances without additional state-level restrictions for Schedule IV substances. A prescriber must hold an active Wyoming medical license (or practice under a multistate compact recognized by Wyoming) and maintain an active DEA registration.

Telehealth visits for modafinil in Wyoming typically last 15 to 30 minutes. During the appointment, your provider will review symptoms, medical history, and any prior sleep study results. Most telehealth platforms operating in Wyoming can send an electronic prescription directly to your preferred pharmacy. Expect to receive a 30- or 90-day supply depending on your insurer's formulary rules and your provider's clinical judgment.

Who Can Prescribe Provigil in Wyoming

Any practitioner with prescriptive authority and an active DEA registration in Wyoming can prescribe modafinil. That includes physicians (MD and DO), nurse practitioners, and physician assistants.

Wyoming grants full practice authority to nurse practitioners under W.S. § 33-21-120, meaning NPs can prescribe Schedule IV controlled substances independently without a collaborative physician agreement [1]. Physician assistants in Wyoming prescribe under a delegation agreement with a supervising physician, and their prescriptive authority extends to Schedule III through V substances per the Wyoming Board of Medicine rules. Both NPs and PAs must hold their own DEA registration to prescribe any controlled substance.

Sleep medicine specialists are not required. A primary care physician, internist, or psychiatrist can diagnose narcolepsy or shift-work disorder and prescribe modafinil based on clinical evaluation and, when indicated, polysomnography results. The original US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) that led to FDA approval demonstrated that modafinil 200 mg and 400 mg significantly reduced excessive daytime sleepiness as measured by the Maintenance of Wakefulness Test and the Epworth Sleepiness Scale [2]. This evidence base supports prescribing by generalist clinicians, not only subspecialists.

What Labs and Documentation You Need Before Starting Modafinil

Modafinil does not require routine baseline laboratory monitoring per the FDA-approved prescribing information. There is no hepatic panel, renal function test, or CBC mandated before initiating therapy. Your prescriber may still order labs based on your individual clinical picture.

For narcolepsy, most providers and most insurers expect documentation of excessive daytime sleepiness. A formal polysomnogram followed by a Multiple Sleep Latency Test (MSLT) is the gold standard for confirming narcolepsy type 1 or type 2. The MSLT diagnostic threshold is a mean sleep latency of <8 minutes with two or more sleep-onset REM periods [3]. If you already have these results from another state, they transfer to Wyoming without needing to repeat the study.

For shift-work disorder, documentation requirements are simpler. A clinical history showing a work schedule that overlaps with the conventional sleep period (typically rotating or night shifts) combined with excessive sleepiness or insomnia related to that schedule is sufficient for diagnosis per the International Classification of Sleep Disorders, Third Edition (ICSD-3) [4].

If your provider plans to use modafinil off-label for conditions like ADHD-related fatigue or cognitive complaints, insurance coverage becomes unlikely and clinical documentation should reflect a clear rationale, treatment alternatives tried, and informed consent.

Insurance Coverage and Prior Authorization in Wyoming

Generic modafinil is covered by most commercial insurance plans in Wyoming, but brand-name Provigil rarely appears on current formularies since Cephalon's patent expired in 2012. Prior authorization is the norm. Here is what Wyoming insurers typically require.

Commercial plans (BCBS Wyoming, Cigna, Aetna, UnitedHealthcare): Prior authorization requests must include the specific diagnosis (ICD-10 code G47.411 for narcolepsy with cataplexy, G47.419 for narcolepsy without cataplexy, or G47.26 for shift-work disorder), supporting sleep study documentation for narcolepsy, and confirmation that the prescribed dose does not exceed 400 mg per day. Most plans approve generic modafinil at tier 2 or tier 3 copay levels once PA is granted. Approval turnaround ranges from 24 to 72 hours for standard requests and 24 hours for urgent requests.

Wyoming Medicaid (EqualityCare): Modafinil is not covered under Wyoming Medicaid. The Wyoming Department of Health's preferred drug list excludes modafinil and armodafinil. Patients on Wyoming Medicaid who need a wake-promoting agent may need to work with their provider on an exception request, though approval rates for these exceptions are low. Alternative covered agents may include certain stimulants depending on the diagnosis and clinical documentation.

Medicare Part D: Coverage varies by plan. Most Medicare Part D formularies include generic modafinil with prior authorization and quantity limits (typically 30 tablets per 30 days). The average Part D copay for generic modafinil in 2025 was $15 to $35 per month at preferred pharmacies [5].

The prior authorization packet for any payer should include: the prescriber's NPI and DEA numbers, patient diagnosis with ICD-10 code, relevant sleep study results or shift-work documentation, prior medication trials (if applicable), and the requested dose and duration.

Pharmacy Access and Pricing in Wyoming

Wyoming has approximately 120 retail pharmacies across the state. Every major chain (Walgreens, Walmart, Albertsons/Safeway) and independent pharmacies stock generic modafinil. Rural areas of Wyoming, where the nearest pharmacy may be 30 or more miles away, benefit from mail-order options.

Retail pricing without insurance: Generic modafinil 200 mg, 30 tablets, typically costs $20 to $45 at Wyoming retail pharmacies. GoodRx and similar discount programs frequently bring the cash price below $20 at Walmart and Costco locations in Cheyenne, Casper, and Laramie. Brand-name Provigil, when available, exceeds $1,200 for 30 tablets and is rarely dispensed.

Mail-order pharmacy: Most commercial insurance plans and Medicare Part D plans allow 90-day modafinil prescriptions via mail-order, often at a lower per-unit cost. The prescriber must write or electronically transmit a 90-day prescription. Wyoming law permits Schedule IV prescriptions to be transmitted electronically from any state where the prescriber is licensed and the patient resides in Wyoming.

503A compounding pharmacies: Wyoming licenses 503A compounding pharmacies that can prepare custom modafinil formulations (such as suspensions for patients who cannot swallow tablets) based on a patient-specific prescription. These pharmacies must comply with Wyoming Board of Pharmacy Chapter 8 compounding rules and USP <795> standards. Compounded modafinil is not interchangeable with commercially manufactured tablets and is typically used only when a patient has a documented clinical need for a non-standard formulation.

Transferring a Modafinil Prescription to Wyoming

If you are moving to Wyoming or temporarily residing in the state, you can transfer a modafinil prescription from another state under specific conditions. Wyoming Board of Pharmacy rules allow one-time transfers of Schedule III through V prescriptions between pharmacies, provided the prescription has remaining refills.

The process works like this: contact your current out-of-state pharmacy and request a transfer to a Wyoming pharmacy of your choice. The receiving Wyoming pharmacist will verify the prescription directly with the transferring pharmacy and document the transfer per federal and state requirements. The original prescription at the sending pharmacy is then voided.

For new prescriptions, your out-of-state provider cannot simply call in a modafinil prescription to a Wyoming pharmacy unless they hold a Wyoming medical license. You will need either a Wyoming-licensed prescriber or a telehealth provider licensed in Wyoming to issue a new prescription. This is where telehealth platforms become especially useful for patients relocating to Wyoming from other states, as many national telehealth services employ providers licensed across multiple states.

Modafinil Dosing and Clinical Expectations

The standard starting dose for modafinil is 200 mg taken once daily in the morning for narcolepsy. For shift-work disorder, the dose is 200 mg taken approximately one hour before the start of the work shift [6]. The maximum recommended dose is 400 mg per day, though clinical trials have not consistently shown 400 mg to be more effective than 200 mg for most patients.

A randomized, double-blind, placebo-controlled trial by the US Modafinil in Narcolepsy Multicenter Study Group found that modafinil 200 mg improved mean sleep latency on the Maintenance of Wakefulness Test from 6.3 minutes at baseline to 9.3 minutes at 9 weeks, compared with minimal change in the placebo group (6.3 to 6.9 minutes, P<0.001) [2]. The 400 mg dose produced a mean sleep latency of 10.5 minutes, a statistically significant but clinically modest gain over 200 mg.

Onset of action is typically 30 to 60 minutes. Duration of effect ranges from 10 to 12 hours, which is why evening dosing is discouraged to avoid insomnia. Common side effects include headache (34% vs. 23% placebo), nausea (11% vs. 3% placebo), and nervousness (7% vs. 3% placebo) [6]. Serious adverse reactions are rare but include Stevens-Johnson syndrome and angioedema, both of which require immediate discontinuation and emergency medical attention.

A 2020 Cochrane systematic review of 10 randomized controlled trials (N=1,466) concluded that modafinil reduces excessive daytime sleepiness in narcolepsy compared with placebo but does not significantly improve cataplexy [7]. This review noted the quality of evidence was moderate, with most trials being industry-sponsored.

Patients with hepatic impairment should use a reduced dose (100 mg daily) per the FDA label. Modafinil is a CYP3A4 inducer and can reduce the effectiveness of hormonal contraceptives. Women using oral contraceptives should use an alternative or additional method of contraception during modafinil treatment and for one month after discontinuation [6].

Off-Label Use Considerations in Wyoming

Modafinil is prescribed off-label for conditions including ADHD, fatigue associated with multiple sclerosis, cancer-related fatigue, and treatment-resistant depression augmentation. Off-label prescribing is legal in Wyoming, as in all US states, but insurance coverage for off-label use is rare without strong peer-reviewed evidence supporting the specific indication.

A randomized controlled trial in the Journal of Clinical Psychiatry (N=136) found that modafinil augmentation improved residual fatigue in patients with major depressive disorder on SSRI therapy compared with placebo, with an effect size (Cohen's d) of 0.45 [8]. Military populations have used modafinil for sustained operations, and a systematic review published in Military Medicine found modafinil maintained cognitive performance during sleep deprivation for up to 40 hours without significant rebound hypersomnia [9].

Wyoming prescribers writing off-label modafinil should document the clinical rationale thoroughly. Patients paying cash for off-label use can expect the same $15 to $45 monthly cost for generic modafinil at Wyoming pharmacies.

Timeline From First Appointment to Medication in Hand

The typical timeline for obtaining modafinil in Wyoming breaks down as follows. A telehealth appointment can often be scheduled within 1 to 3 business days. If no prior authorization is needed (cash-pay patients), the prescription can be filled the same day it is written. If prior authorization is required, add 1 to 3 business days for commercial insurance and up to 5 business days for Medicare Part D.

For patients who need a sleep study before prescribing, the timeline extends significantly. Wyoming has a limited number of accredited sleep centers, primarily in Cheyenne, Casper, and Sheridan. Wait times for polysomnography in Wyoming range from 2 to 6 weeks depending on the facility. Home sleep apnea tests (HSATs) are faster to arrange but are not diagnostic for narcolepsy. Only in-lab polysomnography followed by MSLT can confirm narcolepsy.

Total timeline from initial telehealth visit to medication in hand: as short as 1 to 2 days for patients with existing sleep study documentation and cash payment, or 4 to 8 weeks for patients requiring a new sleep study and insurance prior authorization.